Enteropathy-associated T-cell lymphoma surgery: Difference between revisions
Jump to navigation
Jump to search
Nima Nasiri (talk | contribs) (Created page with "===Surgery=== * Surgery is not the first line treatment option for patients with enteropathy-associated T-cell lymphoma.<ref name="Di SabatinoBiagi2012">{{cite journal|last1...") |
Nima Nasiri (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
===Surgery=== | ===Surgery=== | ||
* Surgery is not the first line treatment option for patients with enteropathy-associated T-cell lymphoma.<ref name="Di SabatinoBiagi2012">{{cite journal|last1=Di Sabatino|first1=A.|last2=Biagi|first2=F.|last3=Gobbi|first3=P. G.|last4=Corazza|first4=G. R.|title=How I treat enteropathy-associated T-cell lymphoma|journal=Blood|volume=119|issue=11|year=2012|pages=2458–2468|issn=0006-4971|doi=10.1182/blood-2011-10-385559}}. Accessed on January 28,2016</ref> | *Surgery is not the first line treatment option for patients with enteropathy-associated T-cell lymphoma.<ref name="Di SabatinoBiagi2012">{{cite journal|last1=Di Sabatino|first1=A.|last2=Biagi|first2=F.|last3=Gobbi|first3=P. G.|last4=Corazza|first4=G. R.|title=How I treat enteropathy-associated T-cell lymphoma|journal=Blood|volume=119|issue=11|year=2012|pages=2458–2468|issn=0006-4971|doi=10.1182/blood-2011-10-385559}}. Accessed on January 28,2016</ref> | ||
* Local [[debulking]] is usually reserved for patients with tumor masses with a high risk of [[obstruction]], [[hemorrhage]], and perforation. | * Local [[debulking]] is usually reserved for patients with tumor masses with a high risk of [[obstruction]], [[hemorrhage]], and perforation. | ||
Revision as of 19:25, 9 January 2019
Surgery
- Surgery is not the first line treatment option for patients with enteropathy-associated T-cell lymphoma.[1]
- Local debulking is usually reserved for patients with tumor masses with a high risk of obstruction, hemorrhage, and perforation.
- ↑ Di Sabatino, A.; Biagi, F.; Gobbi, P. G.; Corazza, G. R. (2012). "How I treat enteropathy-associated T-cell lymphoma". Blood. 119 (11): 2458–2468. doi:10.1182/blood-2011-10-385559. ISSN 0006-4971.. Accessed on January 28,2016